"Don't Accuse Us Of Inexperience, We Are Global Company": Bharat Biotech | Read
Bharat Biotech, whose coronavirus vaccine Covaxin has been given "restricted use in emergency situation in public interest", hit back Monday at criticism that the drug was cleared despite lack of efficacy data. Dr Krishna Ella, the Chief Managing Director of the Hyderabad-based company, pointed to a long list of successful clinical trials in 12 countries as proof the firm's experience and standing.
